Immune-Related Adverse Events Associated with Anti-PD-1/PD-L1 Treatment for Malignancies: A Meta-Analysis.

Wang, Peng-Fei; Chen, Yang; Song, Si-Ying; Wang, Ting-Jian; Ji, Wen-Jun; Li, Shou-Wei; Liu, Ning; Yan, Chang-Xiang

Wang, Peng-Fei; Chen, Yang; Song, Si-Ying; Wang, Ting-Jian; Ji, Wen-Jun; Li, Shou-Wei; Liu, Ning; Yan, Chang-Xiang.

Afiliación

Wang PF; Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, China.
Chen Y; Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, China.
Song SY; State Key Laboratory of Cardiovascular Disease, Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wang TJ; Department of Clinical Medicine, Capital Medical University, Beijing, China.
Ji WJ; Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, China.
Li SW; Key Laboratory, Department of Neurosurgery, The Second Hospital of Yulin, Xi'an Jiaotong University, Xi'an, China.
Liu N; Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, China.
Yan CX; Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, China.

Front Pharmacol ; 8: 730, 2017.

Article en En | MEDLINE | ID: mdl-29093678

Palabras clave

Anti-PD-1 antibodies; immune-related adverse events; immunotherapy; nivolumab; oncology

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies / Systematic_reviews Idioma: En Revista: Front Pharmacol Año: 2017 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google